These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19139348)

  • 1. Rationale for adjunctive topical corticosteroids in bacterial keratitis.
    Hindman HB; Patel SB; Jun AS
    Arch Ophthalmol; 2009 Jan; 127(1):97-102. PubMed ID: 19139348
    [No Abstract]   [Full Text] [Related]  

  • 2. The steroid controversy in bacterial keratitis.
    Acharya NR; Srinivasan M; Mascarenhas J; Ravindran M; Rajaraman R; Zegans M; McLeod S; Lietman TM
    Arch Ophthalmol; 2009 Sep; 127(9):1231. PubMed ID: 19752446
    [No Abstract]   [Full Text] [Related]  

  • 3. The case against the use of steroids in the treatment of bacterial keratitis.
    Cohen EJ
    Arch Ophthalmol; 2009 Jan; 127(1):103-4. PubMed ID: 19139349
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.
    Kaye S; Tuft S; Neal T; Tole D; Leeming J; Figueiredo F; Armstrong M; McDonnell P; Tullo A; Parry C
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):362-8. PubMed ID: 19684005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids in the Management of Infectious Keratitis: A Concise Review.
    Sharma B; Soni D; Mohan RR; Sarkar D; Gupta R; Chauhan K; Karkhur S; Morya AK
    J Ocul Pharmacol Ther; 2021 Oct; 37(8):452-463. PubMed ID: 34448619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful management of Burkholderia cepacia keratitis after LASIK.
    Reddy JC; Tibbetts MD; Hammersmith KM; Nagra PK; Rapuano CJ
    J Refract Surg; 2013 Jan; 29(1):8-9. PubMed ID: 23311735
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems with monotherapy for bacterial keratitis.
    Guzek JP
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6902-3; author reply 6903. PubMed ID: 21123792
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of adjunctive topical corticosteroids in bacterial keratitis.
    Ni N; Srinivasan M; McLeod SD; Acharya NR; Lietman TM; Rose-Nussbaumer J
    Curr Opin Ophthalmol; 2016 Jul; 27(4):353-7. PubMed ID: 27096374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subgroup analysis in the steroids for corneal ulcers trial.
    Dulku S
    Arch Ophthalmol; 2012 Jun; 130(6):807-8; author reply 808. PubMed ID: 22801856
    [No Abstract]   [Full Text] [Related]  

  • 11. LASIK infectious keratitis.
    Das M; Garg P
    Ophthalmology; 2011 Feb; 118(2):425; author reply 425.e1. PubMed ID: 21292114
    [No Abstract]   [Full Text] [Related]  

  • 12. Controversies in management of bacterial keratitis.
    Charukamnoetkanok P; Pineda R
    Int Ophthalmol Clin; 2005; 45(4):199-210. PubMed ID: 16199977
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
    Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000.
    Baum J; Barza M
    Cornea; 2000 Sep; 19(5):659-72. PubMed ID: 11009318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating Infectious Keratitis.
    Cunningham ET; Acharya NR; Akpek EK; Zierhut M
    Ocul Immunol Inflamm; 2016 Oct; 24(5):479-81. PubMed ID: 27681115
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):143-50. PubMed ID: 21987582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis.
    Jain R; Murthy SI; Motukupally SR; Jain M
    Cornea; 2014 Sep; 33(9):923-7. PubMed ID: 25014142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
    Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
    Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; O'Brien KS; Glidden DV; Ray KJ; Oldenburg CE; Zegans ME; Whitcher JP; McLeod SD; Porco TC; Lietman TM; Acharya NR;
    Am J Ophthalmol; 2014 Feb; 157(2):327-333.e3. PubMed ID: 24315294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.